EPO and myelodysplastic syndrome: This study shows that the life span of RBC in MDS patients with EPO>1000 mIU/ml is significantly lower than that in MDS patients with EPO<1000 mIU/ml, which indicates that the life span of RBC in MDS patients with high EPO concentration decreases more seriously.